Guest Entrepreneur Information - February 20, 2003
Jeff Stutzman
Founder/CEO ZNQ3
Mr. Stutzman is the Founder/CEO of both ZNQ3 and Stutzman Pierce, Inc. ZNQ3 created the Dynamic Key Architecture (DKA) model for mobile and enterprise infrastructure security. DKA is a platform independent infrastructure security solution that provides increased non-repudiation through strong authentication and dynamically changing randomized encryption keys which provides significantly higher levels of infrastructure security at much higher throughput speeds than traditional PKI. ZNQ3 DKA requires no certificates, no expensive overhead, nor expensive consultants to implement. DKA provides complete ease of installation, fast throughput, positive session control, total scalability, and significantly lower cost of ownership as compared to PKI. Stutzman Pierce is a high end information security consultancy specializing in Distributed Honeynet placement, operations, and analysis, as well as crisis-mode incident response to the Fortune 100.
Mr. Stutzman has over 18 years of information security experience with employers including Cisco Systems (Information Security), US Navy Intelligence, and the US Coast Guard. Mr. Stutzman was a visiting scientist with Carnegie Mellon Universities Software Engineering Institute (CERT-CC), and is an active member in the Honeynet Project.
Jeremie Spitzer
Cofounder & Interim CEO, ZForm
Zform is building online interactive games designed to bring the blind and sighted together on an equal footing. Jeremy is played a critical part in the conception of the company, the market focus, and its execution. His responsibilities include market research, business plan development, creating a highly respected board of advisors, hiring complementary management talent, raising outside investment, and daily operation of the entity. The company has won a business plan competition at UMass, presented both an elevator pitch and a Business Plan Presentation at the WPI Venture Forum, attracted a CTO who has set Internet standards with the creation of VRML, and launched first product in April 2002 that enjoys a conversion rate from free trial to purchase that is ten times the video game industry average. Zform has been featured in the media, including NPR, The Boston Globe, and CNN.
Chris Golden
Founder, ProSpeed.net
goldenone@prospeed.net
ProSpeed
Chris Golden is founder, President and Chairman of the Board of Prospeed.Net, Inc., a regional ISP and CLEC providing quality Internet access to commercial and residential customers in the northeast Massachusetts area with major emphasis on Lowell, Tyngsboro and Westford.
Mr. Golden currently serves on the WPI Venture Forum Executive Board and as Chairman of the WPI Venture Forum's Program Committee. He also is the founder of three other starts-up companies and has successfully raised investment funds for all three of these ventures. His professional experience covers a broad range of industries and technologies.
Chris is a graduate of the Boston University Masters Program in Business and holds a degree in economics from Lafayette College. His two children are enrolled in undergraduate programs at Loyola in Baltimore and Bridgewater State College in Massachusetts.
Gail Radcliffe
President, Radcliffe Consulting, Inc.
Market Research, Clinical Trials, Project Management
Gail E. Radcliffe, Ph.D. helps biotech start-ups and health care companies with marketing, regulatory and business development issues. Because she has expertise in each of these areas, she brings a unique product development viewpoint to manufacturers and is able to help streamline the overall business strategy. Small biotech companies often develop platform technologies without understanding the broad market potential for their products. Dr. Radcliffe helps identify potential applications for these products and conducts market research so that hard numbers are available for inclusion in business plans. She also conducts technical due diligence. Dr. Radcliffe holds several patents and has worked with clients to obtain Small Business Innovation Research (SBIR) grants that provide funds for development of novel product ideas.
Dr. Radcliffe obtained a Ph.D. in Molecular Biology from Brown University in 1986. She then completed a post-doctoral fellowship in molecular immunology at the University of Massachusetts Medical School. While at GENE-TRAK, in the early 90's, she developed molecular diagnostic assays for several infectious disease organisms including HIV, CMV, MTB and Chlamydia. She later joined Cytyc Corporation to help identify novel applications for the ThinPrep Processor, an instrument that produces thin layer Pap smears.
Dr. Radcliffe was responsible for instituting the clinical affairs group at GENE-TRAK. She helped conduct development studies and forge partnerships with other health care companies while at Cytyc. Some of the projects that she has completed as a consultant in the regulatory area include writing clinical reports for pharmaceutical companies, developing regulatory strategy in concert with the FDA, instituting quality systems, designing and monitoring clinical trials and coordinating documentation for CE marking.
She is a member of the Regulatory Affairs Professional Society (RAPS), American Society of Microbiologists (ASM), Sigma Xi, New England Regional Chapter of the Society of Quality Assurance (NERCSQA) and the Worcester Polytechnic Institute Venture Forum. She is on the editorial board of the journal, Current Pharmaceutical Biotechnology. She is on the Board of Trustees of the Massachusetts Biomedical Initiatives and acts as an advisor to several venture capital companies.
Morey Kraus
Chief Technical Officer, ViaCell Inc.
Kraus is the founder and former president/CEO of t. Breeders, Inc., founded in 1994. In 2000 t. Breeders was renamed ViaCell, Inc. At that time Kraus took on the role of Chief Technical Officer. He is the principal inventor of Selective Amplification, ViaCell's patented technology designed to expand rare populations of primary cells, including Hematopoietic Stem Cells.
Ron Ranauro
WPI '83 MGE MS '88 CS
Executive Vice President and General Manager, Gene-IT
Gene-IT helps bioscience companies discover the functions of genes through comparative genomics. Gene-IT equips customers with the Biofacet™ computational biology software engine and Biofacet SML™, a flexible language for expressing sequence-mining questions. Unlike traditional approaches that require extensive programming for each inquiry, Biofacet frees researchers to ask biological questions - and gain rapid answers - with just a few command lines. Gene-IT customers and collaborative partners include Aventis, DuPont, the European Bioinformatics Institute (EBI), Genoscope, Organon, Pfizer, and Servier.
New technology to sequence genomes is fueling an emerging field of research, comparative genomics. Comparative genomics is the massive and systematic comparison of genomic data from multiple organisms. By comparing whole genomes, scientists learn more about which genes are common among organisms, gene location, gene regulation, and gene structure.
Gene-IT's vision is to bring these comparative genomics solutions within the reach of life science companies and research institutions worldwide, as part of a licensed software agreement, an outsourced service, or a collaborative research project.
Maintained by webmaster@wpi.eduLast modified: May 22, 2007 14:41:06